My NCBISign In
Overexpression of platelet-derived growth factor receptor α in breast cancer is associated with tumour progression
Inês Carvalho, Fernanda Milanezi, Albino Martins, Rui M Reis, Fernando Schmitt
Breast Cancer Res. 2005; 7(5): R788–R795. Published online 2005 August 1. doi: 10.1186/bcr1304
PMCID:
PMC1242156
Abstract Full Text PDF–511K

Is Cited by the Following 16 Articles in this Archive:

PLATELET-DERIVED GROWTH FACTOR-C (PDGF-C) ACTIVATION BY SERINE PROTEASES: IMPLICATIONS FOR BREAST CANCER PROGRESSION
Newton J. Hurst, Jr, Abdo J. Najy, Carolyn V. Ustach, Lisa Movilla, Hyeong-Reh Choi Kim
Biochem J. Author manuscript; available in PMC 2012 May 3.
Published in final edited form as: Biochem J. 2012 February 1; 441(3): 909–918. doi: 10.1042/BJ20111020
PMCID:
PMC3342761
Abstract Full Text PDF–3.3M Supplementary Material
Mammary tumors that become independent of the type I insulin-like growth factor receptor express elevated levels of platelet-derived growth factor receptors
Craig I Campbell, Roger A Moorehead
BMC Cancer. 2011; 11: 480. Published online 2011 November 9. doi: 10.1186/1471-2407-11-480
PMCID:
PMC3254084
Abstract Full Text PDF–10M
Optical fiber-based in vivo quantification of growth factor receptors
Thommey P. Thomas, Yu-Chung Chang, Jing Yong Ye, Alina Kotlyar, Zhengyi Cao, Rameshwer Shukla, Suyang Qin, Theodore B. Norris, James R. Baker, Jr.
Cancer. Author manuscript; available in PMC 2013 January 15.
Published in final edited form as: Cancer. 2012 April 15; 118(8): 2148–2156. Published online 2011 August 25. doi: 10.1002/cncr.26487
PMCID:
PMC3324314
Free in PMC on 2013/01/15
Transcriptional activation of the Axl and PDGFR-α by c-Met through a ras- and Src-independent mechanism in human bladder cancer
Chen-Yun Yeh, Shin-Mei Shin, Hsuan-Heng Yeh, Tsung-Jung Wu, Jyh-Wei Shin, Tsuey-Yu Chang, Giri Raghavaraju, Chung-Ta Lee, Jung-Hsien Chiang, Vincent S Tseng, Yuan-Chii G Lee, Cheng-Huang Shen, Nan-Haw Chow, Hsiao-Sheng Liu
BMC Cancer. 2011; 11: 139. Published online 2011 April 16. doi: 10.1186/1471-2407-11-139
PMCID:
PMC3101176
Abstract Full Text PDF–2.3M Supplementary Material
In vitro effects of imatinib mesylate on radiosensitivity and chemosensitivity of breast cancer cells
Marion T Weigel, Linda Dahmke, Christian Schem, Dirk O Bauerschlag, Katrin Weber, Peter Niehoff, Maret Bauer, Alexander Strauss, Walter Jonat, Nicolai Maass, Christoph Mundhenke
BMC Cancer. 2010; 10: 412. Published online 2010 August 9. doi: 10.1186/1471-2407-10-412
PMCID:
PMC2925350
Abstract Full Text PDF–2.6M
THE ALPHA RECEPTOR FOR PLATELET DERIVED GROWTH FACTOR CONFERS BONE-METASTATIC POTENTIAL TO PROSTATE CANCER CELLS BY LIGAND- AND DIMERIZATION-INDEPENDENT MECHANISMS
Mike R. Russell, Qingxin Liu, Hetian Lei, Andrius Kazlauskas, Alessandro Fatatis
Cancer Res. Author manuscript; available in PMC 2011 May 15.
Published in final edited form as: Cancer Res. 2010 May 15; 70(10): 4195–4203. Published online 2010 May 4. doi: 10.1158/0008-5472.CAN-09-4712
PMCID:
PMC2875778
Abstract Full Text PDF–682K
Targeting Signal Transduction Pathways in Metastatic Breast Cancer: A Comprehensive Review
Lee S. Rosen, Helen Louise Ashurst, Linnea Chap
Oncologist. 2010 March; 15(3): 216–235. Published online 2010 March 3. doi: 10.1634/theoncologist.2009-0145
PMCID:
PMC3227950
Abstract Full Text PDF–925K
Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas
O Martinho, A Longatto-Filho, M B K Lambros, A Martins, C Pinheiro, A Silva, F Pardal, J Amorim, A Mackay, F Milanezi, N Tamber, K Fenwick, A Ashworth, J S Reis-Filho, J M Lopes, R M Reis
Br J Cancer. 2009 September 15; 101(6): 973–982. Published online 2009 August 25. doi: 10.1038/sj.bjc.6605225
PMCID:
PMC2743351
Abstract Full Text PDF–596K
Prognostic Significance of Stromal Platelet-Derived Growth Factor β-Receptor Expression in Human Breast Cancer
Janna Paulsson, Tobias Sjöblom, Patrick Micke, Fredrik Pontén, Göran Landberg, Carl-Henrik Heldin, Jonas Bergh, Donal J. Brennan, Karin Jirström, Arne Östman
Am J Pathol. 2009 July; 175(1): 334–341. doi: 10.2353/ajpath.2009.081030
PMCID:
PMC2708819
Abstract Full Text PDF–1.0M Supplementary Material
Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma
Adhemar Longatto-Filho, Céline Pinheiro, Olga Martinho, Marise AR Moreira, Luiz FJ Ribeiro, Geraldo S Queiroz, Fernando C Schmitt, Fátima Baltazar, Rui M Reis
BMC Cancer. 2009; 9: 212. Published online 2009 June 29. doi: 10.1186/1471-2407-9-212
PMCID:
PMC2711112
Abstract Full Text PDF–2.2M
Up-regulation of miR-21 by HER2/neu Signaling Promotes Cell Invasion
Tzu-Hsuan Huang, Fangting Wu, Gabriel B. Loeb, Ruby Hsu, Amy Heidersbach, Allison Brincat, Dai Horiuchi, Robert J. Lebbink, Yin-Yuan Mo, Andrei Goga, Michael T. McManus
J Biol Chem. 2009 July 3; 284(27): 18515–18524. Published online 2009 May 6. doi: 10.1074/jbc.M109.006676
PMCID:
PMC2709372
Abstract Full Text Supplementary Material
Biological processes, properties and molecular wiring diagrams of candidate low-penetrance breast cancer susceptibility genes
Núria Bonifaci, Antoni Berenguer, Javier Díez, Oscar Reina, Ignacio Medina, Joaquín Dopazo, Víctor Moreno, Miguel Angel Pujana
BMC Med Genomics. 2008; 1: 62. Published online 2008 December 18. doi: 10.1186/1755-8794-1-62
PMCID:
PMC2628924
Abstract Full Text PDF–1.2M Supplementary Material
Imatinib mesylate (Gleevec®) in advanced breast cancer-expressing C-Kit or PDGFR-β: clinical activity and biological correlations
M. Cristofanilli, P. Morandi, S. Krishnamurthy, J. M. Reuben, B.-N. Lee, D. Francis, D. J. Booser, M. C. Green, B. K. Arun, L. Pusztai, A. Lopez, R. Islam, V. Valero, G. N. Hortobagyi
Ann Oncol. 2008 October; 19(10): 1713–1719. Published online 2008 May 29. doi: 10.1093/annonc/mdn352
PMCID:
PMC2735063
Abstract Full Text PDF–497K
Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal-like transitions
Sharon Barr, Stuart Thomson, Elizabeth Buck, Suzanne Russo, Filippo Petti, Izabela Sujka-Kwok, Alexandra Eyzaguirre, Maryland Rosenfeld-Franklin, Neil W. Gibson, Mark Miglarese, David Epstein, Kenneth K. Iwata, John D. Haley
Clin Exp Metastasis. 2008 October; 25(6): 685–693. Published online 2008 January 31. doi: 10.1007/s10585-007-9121-7
PMCID:
PMC2471394
Abstract Full Text PDF–211K
Clinical trials update: endocrine and biological therapy combinations in the treatment of breast cancer
Alexandra F Leary, Bhawna Sirohi, Stephen RD Johnston
Breast Cancer Res. 2007; 9(5): 112. Published online 2007 October 26. doi: 10.1186/bcr1763
PMCID:
PMC2242654
Abstract Full Text PDF–81K
Expression of platelet derived growth factor family members and the potential role of imatinib mesylate for cervical cancer
Lucia Taja-Chayeb, Alma Chavez-Blanco, Jorge Martínez-Tlahuel, Aurora González-Fierro, Myrna Candelaria, Jose Chanona-Vilchis, Elizabeth Robles, Alfonso Dueñas-Gonzalez
Cancer Cell Int. 2006; 6: 22. Published online 2006 October 2. doi: 10.1186/1475-2867-6-22
PMCID:
PMC1601967
Abstract Full Text PDF–1.4M
You are here: NCBI > Literature > PubMed Central (PMC)
Write to the Help Desk